Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy [Phase 3]
Phase 3 trial evaluating early palliative care in patients with metastatic upper gastrointestinal cancers treated with first-line chemothera…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer [Phase 2]
Phase 2 clinical trial exploring neoadjuvant envafolimab with Abraxane and cisplatin for resectable esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy [Phase 2, Phase 3]
Phase 2/3 trial investigating toripalimab plus radiotherapy for elderly esophageal cancer patients managed without chemotherapy; status curr…
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) [Phase 1, Phase 2]
A Phase 1/2 trial assessing safety and feasibility of combining irradiation with nivolumab in esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer [Phase 2]
Phase 2 clinical trial evaluating botulinum toxin type A to prevent complications after esophageal cancer surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma [Phase 2]
Phase 2 trial update evaluating FOLFIRI as second-line chemotherapy for metastatic esophageal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer [Phase 2]
Phase II trial evaluating pembrolizumab with trastuzumab and chemotherapy in advanced HER2-positive esophagogastric cancer has completed and…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial [Phase 2]
A Phase 2 pilot trial examining exercise during neoadjuvant chemoradiation to improve outcomes in rectal and esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating preoperative and adjuvant therapy with carboplatin, nab-paclitaxel, and durvalumab for head and neck squamous cell …
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection [Phase 2]
Phase 2 single-arm pilot studying adjuvant pembrolizumab plus trastuzumab in HER2-positive esophagogastric tumors with persistent circulatin…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of GEN1044 (DuoBody-CD3x5T4) in malignant solid tumors has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer [Phase 3]
Phase 3 trial update of SHR-1210 in combination with chemotherapy in advanced esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for T3011 administered intratumorally in advanced solid tumors, including phase 1 and phase 2 cohorts.
-
FDA approval · 2022-10-18FDA Approved: FLUOROURACIL — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for fluorouracil submitted by Taro Pharmaceuticals U.S.A., Inc., approving changes to the product’s …
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma [Phase 3]
A Phase 3 clinical trial comparing neoadjuvant immunochemotherapy to neoadjuvant chemotherapy for resectable esophageal carcinoma is current…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer [Phase 3]
A Phase 3 trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy in resectable squamous cell esophageal cancer is current…
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer [Phase 2]
A multicenter open-label Phase II trial evaluated nivolumab plus ipilimumab as second-line therapy in elderly patients with advanced esophag…
-
FDA approval · 2022-09-14FDA Approved: FLUOROURACIL — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for fluorouracil submitted by BluePoint Laboratories, indicating approval of an ANDA supplement. Thi…
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, with stated gastric, colon, rectal, esopha…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with combination chemotherapy before surgery for locally advanced esophageal or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer [Phase 2]
Phase II study update for HR070803 in advanced esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer [Phase 2]
Phase 2 trial assessing toripalimab with chemoradiotherapy for unresectable esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer [Phase 2]
Phase 2 trial update examining a biomarker-guided first-line immunotherapy combined with chemotherapy in advanced esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus [Phase 2]
Phase 2 trial evaluating short-course neoadjuvant chemo-radiotherapy plus toripalimab for locoregionally advanced resectable esophageal squa…
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer [Phase 3]
Phase 3 trial investigating trastuzumab and pertuzumab for HER2-positive resectable esophageal cancer (esophageal adenocarcinoma) is current…